Phase II multicenter trial of ipilimumab combined with fotemustine in patients with metastatic melanoma: The Italian Network for Tumor Biotherapy (NIBIT)-M1 trial.

Anna Maria Di Giacomo, Michele Maio, Lorenzo Pilla et al.|Journal of Clinical Oncology|2012

Cited by 7